Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


Articles published in Ann Hematol

Retrieve available abstracts of 91 articles:
HTML format
Text format



Single Articles


    September 2017
  1. GRAZIADEI G, Casoni FM, Annoni F, Cortinovis I, et al
    Transcranial color Doppler in stroke-free adult patients with sickle cell disease.
    Ann Hematol. 2017;96:1547-1555.
    PubMed     Text format     Abstract available


  2. RICCHI P, Meloni A, Costantini S, Spasiano A, et al
    Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
    Ann Hematol. 2017;96:1541-1546.
    PubMed     Text format     Abstract available


  3. RODEGHIERO F, Carli G
    Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
    Ann Hematol. 2017;96:1421-1434.
    PubMed     Text format     Abstract available


    August 2017
  4. ATTA EH, Lima CBL, Dias DSP, Cle DV, et al
    Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Ann Hematol. 2017 Aug 16. doi: 10.1007/s00277-017-3086.
    PubMed     Text format     Abstract available


  5. LI Q, Luo C, Luo C, Wang J, et al
    Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
    Ann Hematol. 2017;96:1389-1397.
    PubMed     Text format     Abstract available


  6. WIEBKING V, Hutker S, Schmid I, Immler S, et al
    Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Ann Hematol. 2017;96:1373-1377.
    PubMed     Text format     Abstract available


    July 2017
  7. ANTUNES FD, Propheta VGS, Vasconcelos HA, Cipolotti R, et al
    Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
    Ann Hematol. 2017;96:1121-1125.
    PubMed     Text format     Abstract available


    June 2017
  8. DE LACERDA MP, Guedes NR, Yamakawa PE, Pereira AD, et al
    Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with (del17p).
    Ann Hematol. 2017 Jun 9. doi: 10.1007/s00277-017-3039.
    PubMed     Text format    


  9. TESSOULIN B, Thomare P, Delande E, Moynard J, et al
    Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
    Ann Hematol. 2017;96:943-950.
    PubMed     Text format     Abstract available


  10. SURAPOLCHAI P, Chuansumrit A, Sirachainan N, Kadegasem P, et al
    A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease.
    Ann Hematol. 2017;96:1005-1014.
    PubMed     Text format     Abstract available


  11. BALDINI M, Marcon A, Ulivieri FM, Seghezzi S, et al
    Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables.
    Ann Hematol. 2017;96:995-1003.
    PubMed     Text format     Abstract available


  12. CASSINERIO E, Baldini IM, Alameddine RS, Marcon A, et al
    Pregnancy in patients with thalassemia major: a cohort study and conclusions for an adequate care management approach.
    Ann Hematol. 2017;96:1015-1021.
    PubMed     Text format     Abstract available


    May 2017
  13. CASTELLI R, Sciara S, Lambertenghi Deliliers G, Pantaleo G, et al
    Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study.
    Ann Hematol. 2017;96:779-786.
    PubMed     Text format     Abstract available


  14. LAI YK, Lai NM, Lee SW
    Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis.
    Ann Hematol. 2017;96:839-845.
    PubMed     Text format     Abstract available


    April 2017
  15. YOUSSRY I, Soliman N, Ghamrawy M, Samy RM, et al
    Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.
    Ann Hematol. 2017;96:597-603.
    PubMed     Text format     Abstract available


  16. ALASHKAR F, Vance C, Herich-Terhurne D, Preising N, et al
    Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.
    Ann Hematol. 2017;96:589-596.
    PubMed     Text format     Abstract available


  17. CHEN M, Zhuang J, Zhou D, Xu Y, et al
    Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
    Ann Hematol. 2017;96:581-587.
    PubMed     Text format     Abstract available


    March 2017
  18. GREGORY GP, Farrell A, Brown S
    Cold agglutinin disease complicated by acrocyanosis and necrosis.
    Ann Hematol. 2017;96:509-510.
    PubMed     Text format    


    February 2017
  19. PUIGVI L, Baumann T, Fernandez S, Castro P, et al
    Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia.
    Ann Hematol. 2017 Feb 21. doi: 10.1007/s00277-017-2957.
    PubMed     Text format    


  20. KLAIHMON P, Phongpao K, Kheansaard W, Noulsri E, et al
    Microparticles from splenectomized beta-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
    Ann Hematol. 2017;96:189-198.
    PubMed     Text format     Abstract available


  21. WANG HC, Hsieh LL, Liu YC, Hsiao HH, et al
    The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
    Ann Hematol. 2017;96:183-188.
    PubMed     Text format     Abstract available


  22. BURKHARDT L, Lobitz S, Koustenis E, Rueckriegel SM, et al
    Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.
    Ann Hematol. 2017;96:199-213.
    PubMed     Text format     Abstract available


    January 2017
  23. OUEDERNI M, Ben Khaled M, Mellouli F, Ben Fraj E, et al
    Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
    Ann Hematol. 2017;96:133-139.
    PubMed     Text format     Abstract available


  24. BOGUSLAWSKA DM, Heger E, Machnicka B, Skulski M, et al
    A new frameshift mutation of the beta-spectrin gene associated with hereditary spherocytosis.
    Ann Hematol. 2017;96:163-165.
    PubMed     Text format    


  25. AL NAJJAR S, Adam S, Ahmed N, Qari M, et al
    Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Ann Hematol. 2017;96:141-146.
    PubMed     Text format     Abstract available


    December 2016
  26. LIANG XH, Rong L, He G, He H, et al
    Polymorphisms of the TGF-beta1 gene and the risk of acquired aplastic anemia in a Chinese population.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  27. OH DH, Motorna O, Kong JB, Brown S, et al
    Linezolid-associated reticulocytopenia.
    Ann Hematol. 2016;95:2095-2097.
    PubMed     Text format    


    November 2016
  28. GROTH M, Singer S, Niedeggen C, Petermann-Meyer A, et al
    Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  29. ZHANG XH, Wang QM, Chen H, Chen YH, et al
    Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation.
    Ann Hematol. 2016;95:1637-43.
    PubMed     Text format     Abstract available


  30. CRISP RL, Maltaneri RE, Vittori DC, Solari L, et al
    Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.
    Ann Hematol. 2016;95:1595-601.
    PubMed     Text format     Abstract available


  31. PHONDEECHAREON T, Wattanapanitch M, U-Pratya Y, Damkham C, et al
    Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
    Ann Hematol. 2016;95:1617-25.
    PubMed     Text format     Abstract available


  32. URESHINO H, Miyahara M
    Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer.
    Ann Hematol. 2016;95:1743-4.
    PubMed     Text format    


  33. HUANG Y, Wang M, Yu C, Lei Y, et al
    Clinical presentation of the hemoglobin Youngstown variant in a Chinese family.
    Ann Hematol. 2016;95:1925-7.
    PubMed     Text format    


  34. BALAIAN E, Schuster C, Schonefeldt C, Germing U, et al
    Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.
    Ann Hematol. 2016;95:1805-10.
    PubMed     Text format     Abstract available


    September 2016
  35. VAGACE JM, Cardesa R, Corbacho A, Vazquez T, et al
    Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.
    Ann Hematol. 2016;95:1419-27.
    PubMed     Text format     Abstract available


  36. LANZA F, Lazzari MC, Brambilla P, Di Martino G, et al
    An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man.
    Ann Hematol. 2016;95:1555-7.
    PubMed     Text format    


  37. HAGIWARA K, Kamesaki T, Kakimoto T, Fukushima K, et al
    Long-term follow-up of non-syphilitic paroxysmal cold hemoglobinuria in an adult.
    Ann Hematol. 2016;95:1547-9.
    PubMed     Text format    


    August 2016
  38. LOW MS, Vilcassim S, Fedele P, Grigoriadis G, et al
    Acute monocytic leukemia masked by hemolytic anemia and sclerotic lesions.
    Ann Hematol. 2016.
    PubMed     Text format    


  39. BAPTISTA LC, Costa ML, Ferreira R, Albuquerque DM, et al
    Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  40. BELISARIO AR, Sales RR, Toledo NE, Muniz MB, et al
    Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  41. ZAREI T, Haghpanah S, Parand S, Moravej H, et al
    Evaluation of bone mineral density in patients with hemoglobin H disease.
    Ann Hematol. 2016;95:1329-32.
    PubMed     Text format     Abstract available


  42. KARIMI M, Haghpanah S, Pishdad P, Rachmilewitz EA, et al
    Frequency of silent cerebral ischemia in patients with transfusion-dependent beta-thalassemia major compared to healthy individuals.
    Ann Hematol. 2016;95:1387.
    PubMed     Text format    


  43. ZAFARI M, Kosaryan M, Gill P, Alipour A, et al
    Non-invasive prenatal diagnosis of beta-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis.
    Ann Hematol. 2016;95:1341-50.
    PubMed     Text format     Abstract available


    July 2016
  44. VISWESHWAR N, Jaglal M, Booth C, Griffin P, et al
    AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy-with large granular lymphocytic leukemia.
    Ann Hematol. 2016.
    PubMed     Text format    


    June 2016
  45. PEREIRA J, Bento C, Manco L, Gonzalez A, et al
    Congenital dyserythropoietic anemia associated to a GATA1 mutation aggravated by pyruvate kinase deficiency.
    Ann Hematol. 2016.
    PubMed     Text format    


  46. RASO S, Napolitano M, Saccullo G, Siragusa S, et al
    Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia.
    Ann Hematol. 2016.
    PubMed     Text format    


  47. DEL ORBE BARRETO R, Arrizabalaga B, De la Hoz Rastrollo AB, Garcia-Orad A, et al
    Hereditary xerocytosis, a misleading anemia.
    Ann Hematol. 2016.
    PubMed     Text format    


  48. UPADHYE D, Jain D, Trivedi Y, Nadkarni A, et al
    Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients.
    Ann Hematol. 2016;95:1201-3.
    PubMed     Text format    


    May 2016
  49. MUSA BM, Galadanci NA, Coker M, Bussell S, et al
    The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  50. KARACAOGLU PK, Asma S, Korur A, Solmaz S, et al
    East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients.
    Ann Hematol. 2016;95:993-1000.
    PubMed     Text format     Abstract available


  51. CARLI G, Visco C, Falisi E, Perbellini O, et al
    Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
    Ann Hematol. 2016;95:863-70.
    PubMed     Text format     Abstract available


  52. PIERINI A, Mancusi A, Terenzi A, Massei MS, et al
    New mechanism of lymphoma-induced bone marrow aplasia.
    Ann Hematol. 2016;95:1013-5.
    PubMed     Text format    


    April 2016
  53. O'NEILL C, Siddiqi I, Brynes RK, Vergara-Lluri M, et al
    Pegylated interferon for the treatment of early myelofibrosis: correlation of serial laboratory studies with response to therapy.
    Ann Hematol. 2016;95:733-8.
    PubMed     Text format     Abstract available


  54. POGGI M, Sorrentino F, Pugliese P, Smacchia MP, et al
    Longitudinal changes of endocrine and bone disease in adults with beta-thalassemia major receiving different iron chelators over 5 years.
    Ann Hematol. 2016;95:757-63.
    PubMed     Text format     Abstract available


  55. LARIBI K, Bolle D, Ghnaya H, Sandu A, et al
    Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.
    Ann Hematol. 2016;95:765-9.
    PubMed     Text format     Abstract available


    March 2016
  56. DAO AT, Yamazaki H, Takamatsu H, Sugimori C, et al
    Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


  57. TODO K, Ohmae T, Osamura T, Imamura T, et al
    Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female.
    Ann Hematol. 2016.
    PubMed     Text format    


  58. KELKITLI E, Ozturk N, Aslan NA, Kilic-Baygutalp N, et al
    Serum zinc levels in patients with iron deficiency anemia and its association with symptoms of iron deficiency anemia.
    Ann Hematol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  59. HUANG Z, Shi J, Shao Y, Nie N, et al
    Clinical profile of megaloblastic anemia in China: a single center experience from MegA-1710 program over two decades.
    Ann Hematol. 2016.
    PubMed     Text format    


  60. PICH A, Godio L, Riera L, Cavaliere C, et al
    Myelodysplastic syndrome with del (5q) and JAK2(V617F) mutation transformed to acute myeloid leukaemia with complex karyotype.
    Ann Hematol. 2016;95:525-7.
    PubMed     Text format    


  61. SORNJAI W, Jaratsittisin J, Khungwanmaythawee K, Svasti S, et al
    Dysregulation of ferroportin gene expression in beta(0)-thalassemia/Hb E disease.
    Ann Hematol. 2016;95:387-96.
    PubMed     Text format     Abstract available


  62. KUNZ JB, Awad S, Happich M, Muckenthaler L, et al
    Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Ann Hematol. 2016;95:397-402.
    PubMed     Text format     Abstract available


  63. KOWSARYAN M, Zafari M
    Which pamidronate protocol is the best for treating osteoporosis in beta-thalassemia major?
    Ann Hematol. 2016;95:383-6.
    PubMed     Text format     Abstract available


  64. DEVECI B, Kurtoglu A, Kurtoglu E, Salim O, et al
    Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia.
    Ann Hematol. 2016;95:375-81.
    PubMed     Text format     Abstract available


    January 2016
  65. KIM JS, Jang JH, Yoon SS, Lee JH, et al
    Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry.
    Ann Hematol. 2016;95:125-33.
    PubMed     Text format     Abstract available


  66. KARIMI M, Toosi F, Haghpanah S, Pishdad P, et al
    The frequency of silent cerebral ischemia in patients with transfusion-dependent beta-thalassemia major.
    Ann Hematol. 2016;95:135-9.
    PubMed     Text format     Abstract available


  67. UZUNOVA L, Hook CE, Gattens M, Burke GA, et al
    Cold antibody autoimmune haemolytic anaemia in a child with diffuse large B cell lymphoma.
    Ann Hematol. 2016;95:151-2.
    PubMed     Text format    


  68. INOUE S, Khan I, Mushtaq R, Sanikommu SR, et al
    Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease.
    Ann Hematol. 2016;95:221-5.
    PubMed     Text format     Abstract available


  69. VAN HAMEL PARSONS V, Gardner K, Patel R, Thein SL, et al
    Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK.
    Ann Hematol. 2016;95:227-32.
    PubMed     Text format     Abstract available


    December 2015
  70. CHANG HH, Lu MY, Peng SS, Yang YL, et al
    The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent beta-thalassemia in Taiwan.
    Ann Hematol. 2015;94:1945-52.
    PubMed     Text format     Abstract available


  71. ANDRES O, Eber S, Speer CP
    Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5'-maleimide binding assay.
    Ann Hematol. 2015;94:1959-64.
    PubMed     Text format     Abstract available


  72. MEHTA PR, Upadhye DS, Sawant PM, Gorivale MS, et al
    Diverse phenotypes and transfusion requirements due to interaction of beta-thalassemias with triplicated alpha-globin genes.
    Ann Hematol. 2015;94:1953-8.
    PubMed     Text format     Abstract available


    November 2015
  73. RAHIMI R, Foroughi AA, Haghpanah S, Bahmanyar M, et al
    Incidence of testicular microlithiasis in patients with beta-thalassemia major.
    Ann Hematol. 2015;94:1785-9.
    PubMed     Text format     Abstract available


    October 2015
  74. VASCONCELOS MC, Nunes MC, Barbosa MM, Fernandes BM, et al
    Left ventricular remodeling in patients with sickle cell disease: determinants factors and impact on outcome.
    Ann Hematol. 2015;94:1621-9.
    PubMed     Text format     Abstract available


    September 2015
  75. BECKER H, Suciu S, Ruter BH, Platzbecker U, et al
    Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MD
    Ann Hematol. 2015.
    PubMed     Text format     Abstract available


  76. ST BERNARD R, Hsia CC
    Safe utilization of ibrutinib with or without steroids in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia.
    Ann Hematol. 2015.
    PubMed     Text format    


  77. REHMAN S, Ahmed P, Saba N, Munir S, et al
    Association of GSTM1 and GSTT1 deletion polymorphisms with Pakistani aplastic anemia patients and controls and meta-analysis.
    Ann Hematol. 2015.
    PubMed     Text format     Abstract available


  78. SAULTZ JN, Wu HM, Cataland S
    Headache prevalence following recovery from TTP and aHUS.
    Ann Hematol. 2015;94:1473-6.
    PubMed     Text format     Abstract available


  79. TABATA R, Tabata C, Yasumizu R, Kojima M, et al
    Severe sustained hypoplastic bone marrow after immunosuppressive therapy in malignant lymphoma cases with anti-centromere protein-B antibody.
    Ann Hematol. 2015;94:1589-91.
    PubMed     Text format    


    August 2015
  80. WU B, Wang W, Li F, Cheng Y, et al
    Angioimmunoblastic T-cell lymphomas presenting as autoimmune hemolytic anemias: clinical manifestations and circulating cytokine features.
    Ann Hematol. 2015;94:1437-9.
    PubMed     Text format    


  81. NEMTSAS P, Arnaoutoglou M, Perifanis V, Koutsouraki E, et al
    Neurological complications of beta-thalassemia.
    Ann Hematol. 2015;94:1261-5.
    PubMed     Text format     Abstract available


    July 2015
  82. TREISTER-GOLTZMAN Y, Peleg R, Biderman A
    Anemia among Muslim Bedouin and Jewish women of childbearing age in Southern Israel.
    Ann Hematol. 2015.
    PubMed     Text format     Abstract available


  83. BIGLIARDI S, Morselli M, Potenza L, Riva G, et al
    Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study
    Ann Hematol. 2015.
    PubMed     Text format    


  84. BOYER T, Grardel N, Copin MC, Roumier C, et al
    Paroxysmal nocturnal hemoglobinuria (PNH) and T cell large granular lymphocyte (LGL) leukemia-an unusual association: another cause of cytopenia in PNH.
    Ann Hematol. 2015.
    PubMed     Text format    


  85. MARTINEZ-LOPEZ J, Jimenez A, Sanchez-Calero J, Monteagudo D, et al
    Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor.
    Ann Hematol. 2015;94:1237-9.
    PubMed     Text format    


  86. BAS M, Gumruk F, Gonc N, Cetin M, et al
    Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with beta-thalassemia major.
    Ann Hematol. 2015;94:1099-104.
    PubMed     Text format     Abstract available


    June 2015
  87. CERVANTES F, Isola IM, Alvarez-Larran A, Hernandez-Boluda JC, et al
    Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.
    Ann Hematol. 2015.
    PubMed     Text format     Abstract available


  88. CASSINERIO E, Roghi A, Orofino N, Pedrotti P, et al
    A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients.
    Ann Hematol. 2015;94:939-45.
    PubMed     Text format     Abstract available


    May 2015
  89. TAO YF, Deng ZF, Liao L, Qiu YL, et al
    Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients.
    Ann Hematol. 2015;94:747-51.
    PubMed     Text format     Abstract available


  90. SO CC, Chan AY, Chan JC, Ma ES, et al
    Alpha thalassemia trait masquerading as hemoglobin H disease due to co-existing primary myelofibrosis.
    Ann Hematol. 2015;94:875-7.
    PubMed     Text format    


  91. KOUTSIS G, Karadima G, Panas M
    Symptomatic striopallidodentate calcinosis (Fahr's syndrome) in a thalassemic patient with hypoparathyroidism.
    Ann Hematol. 2015;94:897-9.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: